The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
Open accessAbstract
Oxidized phospholipids (OxPLs) on apolipoprotein B-100 (apoB-100) particles are strongly associated with lipoprotein [a] (Lp[a]). In this study, we evaluated whether Lp[a] is preferentially the carrier of OxPL in human plasma. The content of OxPL on apoB-100 particles was measured with monoclonal antibody E06, which recognizes the phosphocholine (PC) headgroup of oxidized but not native phospholipids. To assess whether OxPLs were preferentially bound by Lp[a] as opposed to other lipoproteins, immunoprecipitation and ultracentrifugation experiments, in vitro transfer studies, and chemiluminescent ELISAs were performed. Immunoprecipitation of Lp[a] from human plasma with an apolipoprotein [a] (apo[a])-specific antibody demonstrated that more than 85% of E06 reactivity (i.e., OxPL) coimmunoprecipitated with Lp[a]. Ultracentrifugation experiments showed that nearly all OxPLs were found in fractions containing apo[a], as opposed to other apolipoproteins. In vitro transfer studies showed that oxidized LDL preferentially donates OxPLs to Lp[a], as opposed to LDL, in a time- and temperature-dependent manner, even in aqueous buffer. Approximately 50% of E06 immunoreactivity could be extracted from isolated Lp[a] following exposure of plasma to various lipid solvents. These data demonstrate that Lp[a] is the preferential carrier of PC-containing OxPL in human plasma. This unique property of Lp[a] suggests novel insights into its physiological function and mechanisms of atherogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Self-citationWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationHörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationChapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35376-1 · Cited by 553
Self-citationChang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Self-citationPodrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Febbraio, M., Hajjar, D. P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205924200 · Cited by 386
Tsimikas, S., Bergmark, C., Beyer, R. W., Patel, R., Pattison, J., Miller, E., Juliano, J., & Witztum, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02769-9 · Cited by 349
Self-citationApoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory
Chang, M.-K., Binder, C. J., Miller, Y. I., Subbanagounder, G., Silverman, G. J., Berliner, J. A., & Witztum, J. L. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031763 · Cited by 335
Self-citationGargalovic, P. S., Imura, M., Zhang, B., Gharavi, N. M., Clark, M. J., Pagnon, J., Yang, W.-P., He, A., Truong, A., Patel, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605457103 · Cited by 314
Huber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J. L., Binder, B. R., & Leitinger, N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101525 · Cited by 296
Self-citationTsimikas, S., Lau, H. K., Han, K.-R., Shortal, B., Miller, E. R., Segev, A., Curtiss, L. K., Witztum, J. L., & Strauss, B. H. (2004) · Circulation · doi:10.1161/01.cir.0000130844.01174.55 · Cited by 285
Self-citationBinder, C. J., Shaw, P. X., Chang, M.-K., Boullier, A., Hartvigsen, K., Hörkkö, S., Miller, Y. I., Woelkers, D. A., Corr, M., & Witztum, J. L. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500005-jlr200 · Cited by 253
Self-citationKiechl, S., Willeit, J., Mayr, M., Viehweider, B., Oberhollenzer, M., Kronenberg, F., Wiedermann, C. J., Oberthaler, S., Xu, Q., Witztum, J. L., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145805 · Cited by 250
Self-citationLipoprotein(a): An Elusive Cardiovascular Risk Factor
Berglund, L., & Ramakrishnan, R. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000144010.55563.63 · Cited by 242
Caplice, N. M., Panetta, C., Peterson, T. E., Kleppe, L. S., Mueske, C. S., Kostner, G. M., Broze, G. J., & Simari, R. D. (2001) · Blood · doi:10.1182/blood.v98.10.2980 · Cited by 228
Tsimikas, S., Witztum, J. L., Miller, E. R., Sasiela, W. J., Szarek, M., Olsson, A. G., & Schwartz, G. G. (2004) · Circulation · doi:10.1161/01.cir.0000141728.23033.b5 · Cited by 225
Self-citationSuk Danik, J., Rifai, N., Buring, J. E., & Ridker, P. M. (2006) · JAMA · doi:10.1001/jama.296.11.1363 · Cited by 216
Tsimikas, S., Kiechl, S., Willeit, J., Mayr, M., Miller, E. R., Kronenberg, F., Xu, Q., Bergmark, C., Weger, S., Oberhollenzer, F., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.001 · Cited by 197
Self-citationFriedman, P., Hörkkö, S., Steinberg, D., Witztum, J. L., & Dennis, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108860200 · Cited by 195
Self-citationLipoprotein(a): intrigues and insights
Hobbs, H. H., & White, A. L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00005 · Cited by 179
Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein
Gillotte-Taylor, K., Boullier, A., Witztum, J. L., Steinberg, D., & Quehenberger, O. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30281-9 · Cited by 165
Self-citationEdelstein, C., Pfaffinger, D., Hinman, J., Miller, E. R., Lipkind, G. M., Tsimikas, S., Bergmark, C., Getz, G. S., Witztum, J. L., & Scanu, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310425200 · Cited by 137
Self-citationBerg, K., Dahlén, G. H., Christophersen, B. O., Cook, T. J., KJEKSHUS, J. K., & Pedersen, T. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb04342.x · Cited by 136
Silaste, M.-L., Rantala, M., Alfthan, G., Aro, A., Witztum, J. L., Kesäniemi, Y. A., & Hörkkö, S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118012.64932.f4 · Cited by 126
Self-citationPhosphocholine as a pattern recognition ligand for CD36
Boullier, A., Friedman, P., Harkewicz, R., Hartvigsen, K., Green, S. R., Almazan, F., Dennis, E. A., Steinberg, D. H., Witztum, J. L., & Quehenberger, O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400496-jlr200 · Cited by 122
Self-citationPillarisetti, S., Paka, L., Obunike, J. C., Berglund, L., & Goldberg, I. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119602 · Cited by 112
Blencowe, C., Hermetter, A., Kostner, G. M., & Deigner, H. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31151 · Cited by 110
Witztum, J. L., Young, S. G., Elam, R. L., Carew, T. E., & Fisher, M. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34408-4 · Cited by 108
Self-citationRodenburg, J., Vissers, M. N., Wiegman, A., Miller, E. R., Ridker, P. M., Witztum, J. L., Kastelein, J. J. P., & Tsimikas, S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.047 · Cited by 92
Self-citationGillotte, K. L., Hörkkö, S., Witztum, J. L., & Steinberg, D. H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32391-9 · Cited by 92
Self-citationThe Recurring Evolution of Lipoprotein(a)
Lawn, R. M., Boonmark, N. W., Schwartz, K., Lindahl, G. E., Wade, D. P., Byrne, C. D., Fong, K. J., Meer, K., & Patthy, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24004 · Cited by 89
Tsimikas, S., Aikawa, M., Miller, F. J., Miller, E. R., Torzewski, M., Lentz, S. R., Bergmark, C., Heistad, D. D., Libby, P., & Witztum, J. L. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251501.86410.03 · Cited by 83
Self-citationLipoprotein(a): still an enigma?
Kostner, K., & Kostner, G. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200208000-00006 · Cited by 70
Schneider, M., Witztum, J. L., Young, S. G., Ludwig, E. H., Miller, E. R., Tsimikas, S., Curtiss, L. K., Marcovina, S. M., Taylor, J. M., Lawn, R. M., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400467-jlr200 · Cited by 61
Self-citationPAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro
Karabina, S.-A. P., Elisaf, M., Goudevenos, J. A., Siamopoulos, K. C., Sideris, D. A., & Tselepis, A. D. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05872-8 · Cited by 53
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease
Tsironis, L. D., Katsouras, C. S., Lourida, E. S., Mitsios, J. V., Goudevenos, J. A., Elisaf, M., & Tselepis, A. D. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.030 · Cited by 46
Apolipoprotein(a): structure and biology
Angelo, M. S. (2001) · Frontiers in bioscience · doi:10.2741/scanu · Cited by 36
Reardon, C. A., Miller, E. R., Blachowicz, L., Lukens, J. R., Binder, C. J., Witztum, J. L., & Getz, G. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400075-jlr200 · Cited by 31
Self-citationEvidence That Reduced Heparan Sulfate Promotes Lipoprotein Binding to Subendothelial Matrix
Pillarisetti, S., Paka, L., Obunike, J. C., Berglund, L., & Goldberg, I. J. (1997) · Cited by 25
Devlin, C. M., Lee, S., Kuriakose, G., Spencer, C. A., Becker, L., Grosskopf, I., Ko, C., Huang, L.-S., Koschinsky, M. L., Cooper, A. D., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000170819.57945.03 · Cited by 22
Cited by
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
A Test in Context: Lipoprotein(a)
Tsimikas, S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.042 · Cited by 1,137
Self-citationvan der Valk, F. M., Bekkering, S., Kroon, J., Yeang, C., Van den Bossche, J., van Buul, J. D., Ravandi, A., Nederveen, A. J., Verberne, H. J., Scipione, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.020838 · Cited by 674
Self-citationStructure, function, and genetics of lipoprotein (a)
Schmidt, K., Noureen, A., Kronenberg, F., & Utermann, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067314 · Cited by 638
Generation and Biological Activities of Oxidized Phospholipids
Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., Levonen, A.-L., Binder, C. J., & Stöckl, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2597 · Cited by 610
Self-citation
Metadata
- Authors
- Bergmark, C., Dewan, A., Orsoni, A., Merki, E., Miller, E. R., Shin, M.-J., Binder, C. J., Hörkkö, S., Krauss, R. M., Chapman, M. J., Witztum, J. L., & Tsimikas, S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 49
- Issue
- 10
- Pages
- 2230-2239
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2142686113
- Cited by
- 407
- References
- 43
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.